In October 2021, dad David Jones-Stanley was diagnosed with stage three oesophageal cancer at age 47. He speaks to the M.E.N ...
A research team at Tohoku University, in collaboration with Denka Company Limited and U-A Corporation, has developed a ...
EndoQuest Robotics announced today that the FDA approved the initiation of the next and final stage of its PARADIGM trial.
EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a robotic endoluminal system for gastrointestinal procedures. The ...